8-K Filing

Company

Vistagen Therapeutics, Inc.

Filed

October 16, 2012

Period of Report

October 10, 2012

Accession Number

0001415889-12-001496

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →